vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Fluent, Inc. (FLNT). Click either name above to swap in a different company.

Fluent, Inc. is the larger business by last-quarter revenue ($61.8M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). Fluent, Inc. runs the higher net margin — -6.7% vs -19.9%, a 13.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -5.5%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -3.2%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

THG Fluently, formerly Language Connect, is a translation and language localisation service provided by THG Ingenuity. It provides a range of language services, including translation, interpreting, localisation, voice-overs, transcription, and multilingual search engine optimization.

ABCL vs FLNT — Head-to-Head

Bigger by revenue
FLNT
FLNT
1.4× larger
FLNT
$61.8M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+793.9% gap
ABCL
788.4%
-5.5%
FLNT
Higher net margin
FLNT
FLNT
13.3% more per $
FLNT
-6.7%
-19.9%
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-3.2%
FLNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
FLNT
FLNT
Revenue
$44.9M
$61.8M
Net Profit
$-8.9M
$-4.1M
Gross Margin
Operating Margin
-63.7%
0.3%
Net Margin
-19.9%
-6.7%
Revenue YoY
788.4%
-5.5%
Net Profit YoY
73.9%
-20.1%
EPS (diluted)
$-0.03
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
FLNT
FLNT
Q4 25
$44.9M
$61.8M
Q3 25
$9.0M
$47.0M
Q2 25
$17.1M
$44.7M
Q1 25
$4.2M
$55.2M
Q4 24
$5.0M
$65.4M
Q3 24
$6.5M
$64.5M
Q2 24
$7.3M
$58.7M
Q1 24
$10.0M
$66.0M
Net Profit
ABCL
ABCL
FLNT
FLNT
Q4 25
$-8.9M
$-4.1M
Q3 25
$-57.1M
$-7.6M
Q2 25
$-34.7M
$-7.2M
Q1 25
$-45.6M
$-8.3M
Q4 24
$-3.4M
Q3 24
$-51.1M
$-7.9M
Q2 24
$-36.9M
$-11.6M
Q1 24
$-40.6M
$-6.3M
Operating Margin
ABCL
ABCL
FLNT
FLNT
Q4 25
-63.7%
0.3%
Q3 25
-851.8%
-13.4%
Q2 25
-290.2%
-15.9%
Q1 25
-1479.6%
-12.8%
Q4 24
-8.3%
Q3 24
-1439.4%
-6.0%
Q2 24
-1276.2%
-17.7%
Q1 24
-551.5%
-6.0%
Net Margin
ABCL
ABCL
FLNT
FLNT
Q4 25
-19.9%
-6.7%
Q3 25
-637.8%
-16.1%
Q2 25
-203.3%
-16.2%
Q1 25
-1077.2%
-15.0%
Q4 24
-5.2%
Q3 24
-785.4%
-12.3%
Q2 24
-504.3%
-19.8%
Q1 24
-408.0%
-9.5%
EPS (diluted)
ABCL
ABCL
FLNT
FLNT
Q4 25
$-0.03
$-0.09
Q3 25
$-0.19
$-0.27
Q2 25
$-0.12
$-0.30
Q1 25
$-0.15
$-0.39
Q4 24
$-0.12
Q3 24
$-0.17
$-0.48
Q2 24
$-0.13
$-0.75
Q1 24
$-0.14
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
FLNT
FLNT
Cash + ST InvestmentsLiquidity on hand
$128.5M
$12.9M
Total DebtLower is stronger
$34.6M
Stockholders' EquityBook value
$966.9M
$18.2M
Total Assets
$1.4B
$89.1M
Debt / EquityLower = less leverage
1.90×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
FLNT
FLNT
Q4 25
$128.5M
$12.9M
Q3 25
$83.2M
$9.2M
Q2 25
$92.4M
$4.9M
Q1 25
$159.3M
$4.8M
Q4 24
$156.3M
$9.4M
Q3 24
$126.6M
$6.6M
Q2 24
$148.3M
$5.0M
Q1 24
$123.6M
$11.7M
Total Debt
ABCL
ABCL
FLNT
FLNT
Q4 25
$34.6M
Q3 25
$26.0M
Q2 25
$23.2M
Q1 25
$25.6M
Q4 24
$35.6M
Q3 24
$37.9M
Q2 24
$33.3M
Q1 24
$31.0M
Stockholders' Equity
ABCL
ABCL
FLNT
FLNT
Q4 25
$966.9M
$18.2M
Q3 25
$964.0M
$21.6M
Q2 25
$1.0B
$19.1M
Q1 25
$1.0B
$22.0M
Q4 24
$1.1B
$25.0M
Q3 24
$1.1B
$20.0M
Q2 24
$1.1B
$27.5M
Q1 24
$1.1B
$28.7M
Total Assets
ABCL
ABCL
FLNT
FLNT
Q4 25
$1.4B
$89.1M
Q3 25
$1.4B
$76.1M
Q2 25
$1.4B
$74.5M
Q1 25
$1.3B
$77.5M
Q4 24
$1.4B
$93.6M
Q3 24
$1.4B
$77.5M
Q2 24
$1.4B
$98.5M
Q1 24
$1.5B
$103.6M
Debt / Equity
ABCL
ABCL
FLNT
FLNT
Q4 25
1.90×
Q3 25
1.21×
Q2 25
1.21×
Q1 25
1.16×
Q4 24
1.43×
Q3 24
1.90×
Q2 24
1.21×
Q1 24
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
FLNT
FLNT
Operating Cash FlowLast quarter
$-34.7M
$2.8M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
FLNT
FLNT
Q4 25
$-34.7M
$2.8M
Q3 25
$-52.6M
$-7.3M
Q2 25
$-32.4M
$935.0K
Q1 25
$-11.6M
$2.1M
Q4 24
$-108.6M
$-2.1M
Q3 24
$-28.9M
$1.2M
Q2 24
$-30.0M
$-13.1M
Q1 24
$-41.7M
$-132.0K
Free Cash Flow
ABCL
ABCL
FLNT
FLNT
Q4 25
$-44.6M
Q3 25
$-61.5M
$-7.3M
Q2 25
$-45.8M
Q1 25
$-22.2M
Q4 24
$-187.0M
Q3 24
$-47.4M
$1.2M
Q2 24
$-50.1M
Q1 24
$-65.8M
FCF Margin
ABCL
ABCL
FLNT
FLNT
Q4 25
-99.4%
Q3 25
-687.0%
-15.6%
Q2 25
-267.9%
Q1 25
-524.0%
Q4 24
-3702.8%
Q3 24
-728.4%
1.9%
Q2 24
-683.8%
Q1 24
-661.5%
Capex Intensity
ABCL
ABCL
FLNT
FLNT
Q4 25
21.9%
Q3 25
99.7%
0.0%
Q2 25
78.2%
Q1 25
251.1%
Q4 24
1552.7%
Q3 24
284.6%
0.0%
Q2 24
274.6%
Q1 24
242.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

FLNT
FLNT

Commerce Media Solutions$34.7M56%
Owned And Operated$21.3M34%
Call Solutions$3.8M6%
Ad Parlor$2.0M3%

Related Comparisons